For patients currently on Mounjaro who are interested in eventually transitioning to retatrutide, here is a realistic timeline based on available information: Phase 3 trials complete and data is analyzed
Cochrane Database of Systematic Reviews , CD001287
By clicking "Accept", you consent to our use of cookies.
S-adenosylmethionine metabolism and liver disease
Company : FuturHealth Address : FuturHealth Inc 325 W Washington St Ste 2 - 944 San Diego, CA 92103 Email : [email protected] Phone Support : (831) 900-4723 Disclaimer General Disclaimer This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment
Specifically, researchers looked at the rate of discontinuation of the drugs due to adverse events compared to placebo groups and found higher rates of nausea, vomiting and diarrhea